Steven E. Wilson, MD’s discovery of topical losartan treatment to prevent and treat corneal scarring fibrosis that results in severe vision loss or blindness has revolutionized medical care for patients with corneal trauma, chemical burns, infections (bacterial, fungal, viral, acanthamoeba, chlamydia).